Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1990Clinical Infectious Diseases

2′,3′-Dideoxyinosine in Patients with AIDS or AIDS-Related Complex

View Full Paper
Ask AI
Bookmark
Share

Authors

RDRaphael DolinBeth Israel Deaconess Medical CenterJLJohn S. LambertMater Misericordiae University HospitalGMGene D. MorseUniversity at Buffalo, State University of New York

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dolin et al. (1990) studied this question.

synapsesocial.com/papers/6a9ff68b60d48b6184618b1fhttps://doi.org/10.1093/clinids/12.supplement_5.s540
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex1987 · 2,995 citations
  2. 2Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.1989 · 290 citations
  3. 3HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy1989 · 1,565 citations
  4. 4In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-Dideoxyinosine1989 · 425 citations